The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|19 Apr 2017||Submitted||Original manuscript|
|29 May 2017||Reviewed||Reviewer Report - Jann-Yuan Wang|
|10 Jun 2017||Reviewed||Reviewer Report - Rachel Thomson|
|5 Jul 2017||Author responded||Author comments - Kazuma Yagi|
|Resubmission - Version 2|
|5 Jul 2017||Submitted||Manuscript version 2|
|7 Jul 2017||Reviewed||Reviewer Report - Jann-Yuan Wang|
|1 Aug 2017||Author responded||Author comments - Kazuma Yagi|
|Resubmission - Version 3|
|1 Aug 2017||Submitted||Manuscript version 3|
|2 Aug 2017||Editorially accepted|
|9 Aug 2017||Article published||10.1186/s12879-017-2665-5|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.